Pulse Biosciences enters equity distribution deal for up to USD 85 million share sale
PLSE•Prior sales agreement
The program follows an August 2026 sales agreement for up to USD 75 million; 1,379,925 shares were sold for about USD 68.8 million.
At-the-market equity agreement
Pulse Biosciences set an at-the-market equity distribution agreement with Mizuho Securities USA to sell up to USD 85 million of common stock.
- Mizuho earns a commission of up to 3% of gross proceeds.
- The company can pause sales or sell no shares.
Related News
Nasdaq Trade Halt <HVIIU.O> Volatility Trading Pause at 03:58 PM
HVIIU•
Norfolk Southern CEO Says Higher Fuel Prices Have Become Roughly 250-Basis-Point Headwind To Co's Operating Ratio, Leaving Q3 Performance Likely Worse Than Seasonal Trends - Morgan Stanley Conf.
NSC•
